Abstract: The invention refers to a probiotic food supplement comprising a blend of strains of lactobacilli and bifidobacteria synergistically interacting with food (for instance milk) assuring thereby an improved beneficial effect on human health, with special reference to 0-6 months babies, weaning babies, breastfed and formula fed infants as well as lactating mothers. Synergistic blends, which may also be defined as synteractive, have been designed to maximise their probiotic action when assumed with milk and/or food, in whatever state or formulation.

Abstract: A fermented food product or food supplement comprising a vegetable substrate fermented by a probiotic blend is disclosed. The fermented food product or food supplement according to the invention is useful in particular for improving natural maternity, lactation and baby weaning. The invention also discloses a process for the preparation of the fermented food product or food supplement comprising the fermentation of a vegetal substrate with the probiotic blend.

Abstract: The present invention refers to a new strain belonging to the species Lactobacillus paracasei able to convert linoleic acid into conjugated linoleic acid. The present invention refers also to nutritional or food preparations and/or pharmaceutical compositions, comprising the strain Lactobacillus paracasei, useful in the treatment and/or prevention of pathologies and/or physiological states related to conjugated linoleic acid deficiency or in the cases wherein the use of a probiotic is beneficial.

Abstract: The present invention relates to the strain of Lactobacillus reuteri LMG P-27481 provided with anti-inflammatory activity, immunomodulatory activity and capability of inhibiting pathogenic microorganisms. The microorganism can result to be useful and contribute as probiotic in improving the man health status and preventing and/or treating gastrointestinal disturbances, with particular reference to the treatment of diarrhoea caused by Clostridium difficile. The invention also relates to pharmaceutical compositions or food or medical devices comprising the strain of Lactobacillus reuteri LMG P-27481.

Abstract: The present invention refers to a new strain belonging to the species Lactobacillus paracasei able to convert linoleic acid into conjugated linoleic acid. The present invention refers also to nutritional or food preparations and/or pharmaceutical compositions, comprising the strain Lactobacillus paracasei, useful in the treatment and/or prevention of pathologies and/or physiological states related to conjugated linoleic acid deficiency or in the cases wherein the use of a probiotic is beneficial.

Abstract: The present invention refers to a new strain belonging to the species Lactobacillus paracasei able to convert linoleic acid into conjugated linoleic acid. The present invention refers also to nutritional or food preparations and/or pharmaceutical compositions, comprising the strain Lactobacillus paracasei, useful in the treatment and/or prevention of pathologies and/or physiological states related to conjugated linoleic acid deficiency or in the cases wherein the use of a probiotic is beneficial.

Abstract: A growth medium adapted for the growth of a variety of different lactobacilli is provided. The medium is based on milk which is supplemented by at least four free amino acids, at least two ribonucleosides or other ribonulcleotide precursors, and iron. A variety of different Lactobacilli, particularly Lactobacilli belonging to Johnson's group A and B groups, are able to reproduce at rates approximately the same as milk supplemented with yeast extract. This medium when used in the production of dairy products that contain Lactobacilli does not contain the off-flavor of a fermented medium that had been supplemented with yeast extract.

Abstract: The present invention relates to a novel defined medium suitable to cultivate lactic acid bacteria, such as Lactobaccilus or Bifidobacteria. In particular the present invention pertains to the use of said medium for the isolation of bioactive molecules or functional metabolites.